Minority Patients Less Likely to Get Newer Alzheimer’s Meds
TUESDAY, Oct. 4, 2022 (HealthDay News) — While certain minority groups are more likely to be diagnosed with dementia than their white counterparts, they may also be less likely to be eligible for new disease-slowing treatments, a new study finds. Cognitive, or mental, impairment in Black, Hispanic and Asian patientsContinue Reading